AR-67

7-t-butyldimethylsilyl-10-hydroxycamptothecin · University of Kentucky

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AR-67, covering 2013-08-14 to 2014-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma [Phase 2]